AJR ARRS: Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mori, K.
Right arrow Articles by Saida, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mori, K.
Right arrow Articles by Saida, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2005; 184:63-69
© American Roentgen Ray Society

Triple Arterial Phase Dynamic MRI with Sensitivity Encoding for Hypervascular Hepatocellular Carcinoma: Comparison of the Diagnostic Accuracy Among the Early, Middle, Late, and Whole Triple Arterial Phase Imaging

Kensaku Mori1, Hiroshi Yoshioka2, Nobuyuki Takahashi1, Masayuki Yamaguchi1, Teruko Ueno1, Toshihiro Yamaki3 and Yukihisa Saida4

1 Department of Radiology, Institute of Clinical Medicine, University of Tsukuba, Tennodai 1-1-1, Tsukuba, Ibaraki 305-8575, Japan.
2 Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115.
3 Department of Radiology, Asahikawa Medical College, Asahikawa 078-8510, Japan.
4 Department of Diagnostic Imaging, National Hospital Organization Mito Medical Center, Mito, Ibaraki 311-3117, Japan.

OBJECTIVE. We assessed and compared the diagnostic accuracy of the early, middle, late, and whole triple arterial phase MRI with sensitivity encoding (SENSE) for the detection of hypervascular hepatocellular carcinoma (HCC).

MATERIALS AND METHODS. Thirty-one patients with 102 HCCs underwent dynamic MRI with SENSE. The findings of CT examinations, combined with those of visceral angiography or histopathologic examination, were used as the gold standard. After acquisition of T1- and T2-weighted images, gadolinium-enhanced triple arterial, portal, and delayed phase images were obtained. Acquisition of the triple arterial phase imaging was started at the timing of peak aortic enhancement and completed within a single breath-hold. Acquisition time for each phase was 8.4 sec. Four image sets including the early, middle, late, and whole triple arterial phase imaging were interpreted separately by four observers. The mean values of area under alternative-free-response receiver operating characteristic (AFROC) curve and of sensitivity were compared among the four image sets.

RESULTS. The mean values of area under AFROC curve were 0.52, 0.66, 0.53, and 0.68 and of sensitivity were 45%, 64%, 48%, and 65% for the image sets with the early, middle, late, and whole triple arterial phase imaging, respectively. Both mean values were significantly higher for the image sets with the middle and whole triple arterial phase imaging than for those with the early and late arterial phase imaging.

CONCLUSION. The middle arterial phase imaging with k-space centered at 12.6 sec after the peak aortic enhancement was optimal for detecting HCC and showed diagnostic accuracy equivalent to that of the whole triple arterial phase imaging.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
S. Goshima, M. Kanematsu, H. Kondo, Y. Shiratori, M. Onozuka, N. Moriyama, and K. T. Bae
Optimal Acquisition Delay for Dynamic Contrast-Enhanced MRI of Hypervascular Hepatocellular Carcinoma
Am. J. Roentgenol., March 1, 2009; 192(3): 686 - 692.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. A. Sohaib, D.-M. Koh, and J. E. Husband
The Role of Imaging in the Diagnosis, Staging, and Management of Testicular Cancer
Am. J. Roentgenol., August 1, 2008; 191(2): 387 - 395.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. H. Choi, J. M. Lee, N. C. Yu, K.-S. Suh, J.-J. Jang, S. H. Kim, and B. I. Choi
Hepatocellular Carcinoma in Liver Transplantation Candidates: Detection with Gadobenate Dimeglumine-Enhanced MRI
Am. J. Roentgenol., August 1, 2008; 191(2): 529 - 536.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. M. Willatt, H. K. Hussain, S. Adusumilli, and J. A. Marrero
MR Imaging of Hepatocellular Carcinoma in the Cirrhotic Liver: Challenges and Controversies
Radiology, May 1, 2008; 247(2): 311 - 330.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
S. N. Gandhi, M. A. Brown, J. G. Wong, D. A. Aguirre, and C. B. Sirlin
MR Contrast Agents for Liver Imaging: What, When, How
RadioGraphics, November 1, 2006; 26(6): 1621 - 1636.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Roentgen Ray Society.